Investornewsbreaks Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Enters Option Agreement To ...
Scinai Immunotherapeutics (NASDAQ: SCNI) , announced it has signed a binding option agreement to acquire Pincell srl, an Italian biotech developing P ...
Scinai signs an option agreement to acquire rare disease company Pincell and its novel ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company specializing in inflammation and immunology (I&I) ...